Chan Henry Lee - Sep 30, 2024 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role
SVP, General Counsel
Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
Sep 30, 2024
Transactions value $
-$284,994
Form type
4
Date filed
10/2/2024, 07:13 PM
Previous filing
Aug 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE American Depositary Shares Sale -$285K -1.2K -100% $237.10 0 Sep 30, 2024 Direct F1, F2
holding BGNE Ordinary Shares 237K Sep 30, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each American Depositary Share represents 13 Ordinary Shares.
F2 The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2023, as most recently amended on February 28, 2024.